News

Warning not to share ADHD medicine, as shortage bites

ADHD medication shortages in New Zealand have led to warnings against sharing prescriptions, as some patients struggle to access consistent supplies. ADHD New Zealand highlights the global methylphenidate shortage, causing panic for many.

With the new publicly funded option, lisdexamfetamine, hopes are to ease pressure, but long waiting lists and cost barriers remain. Alternatives like ADHD coaching and therapies are being recommended for those facing challenges.

For more details, visit Pharmacy Today.